Glioma Clinical Trials in Commack, New York

4 studies are recruiting for glioma in Commack, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Mirdametinib in People With Central Nervous System Tumors

    The purpose of this study to find out whether mirdametinib is a safe and effective treatment for Central Nervous System/CNS tumors (glioma and neurohistiocytosis).

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT07539441 on ClinicalTrials.gov

  2. Glioma Developmental and HyperActive Ras Tumor (DHART) Board

    This study will collect medical records, scan results, and complete surveys to create a registry about people with a neurofibromatosis type 1-associated brain tumor (NF1-associated glioma). A registry is a collection of health information about individuals, and it is usually focused on a specific d…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT05489783 on ClinicalTrials.gov

  3. Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

    This study will test the safety and effectiveness of a combination of pembrolizumab, olaparib, and temozolomide to see how well these drugs work when given together in people with a glioma that either did not respond to previous treatment or came back after treatment.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Suffolk -Commack (Limited Protocol Activities), Commack, New York
    Locations
    10 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT05188508 on ClinicalTrials.gov

  4. A Study of 177Lu-PSMA-617 in People With Gliomas

    The researchers are doing this study to find out whether the radiopharmaceutical therapy (RPT) 177Lu-PSMA-617 is a safe treatment for people with IDH wild type glioma.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT07223034 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.